GEN Exclusives

More »

Feature Articles

More »
Dec 1, 2013 (Vol. 33, No. 21)

Genomic Healthcare Solutions

  • It seems inevitable that human whole-genome sequencing will dramatically change the practice of healthcare in the next decade. Early disease detection and personalized and directed healthcare interventions are just a few areas where genomic sequencing technology may have a clear value proposition.

    But if clinical application of genome sequencing is to become a reality, we still need to reach several milestones. We need to demonstrate that whole-genome sequencing truly has a potential to save both lives and reduce healthcare costs. We need to improve the diagnostic quality and drastically reduce the costs of informatics analysis. We need to develop a regulatory environment similar to what is currently experienced by clinical labs. And we need to enhance the education of all healthcare professionals and generate greater awareness among future users. It feels like a long way to go. Or is it?

    A tremendous amount of pilot work is already being done, radically transforming current mechanisms for translating genomic advances into improved healthcare. The contributors to this article describe the pioneering research they are pursuing and how it is bridging genomics and medicine to bring about the rational use of genomics technology in clinical practice.

    “Are we ready to use genomic information to change our lifestyles or seek additional medical care?” asks Joseph Jarvis, Ph.D., senior research scientist, Coriell Institute for Medical Research. “The application of the clinical genome is only as valuable as our willingness to use it for healthcare decisions.”

  • Click Image To Enlarge +
    Participants in the the Coriell Personalized Medicine Collaborative (CPMC) study provide a saliva sample for DNA analysis in Cornell’s Genotyping and Microarray Center using CLIA-certified genotyping platforms. The CPMC study represents an attempt to broaden informed consent, one facet of translating genomics into better clinical care.

    Dr. Jarvis concentrates his efforts on the Coriell Personalized Medicine Collaborative (CPMC), which aims to answer how best to deliver genetic risk information to users.

    More than 7,500 individuals are grouped into the CPMC’ s four longitudinal cohorts, including a segment representing the United States Air Force Medical Service, an elite organization eager to learn more about the clinical utility of genetic information. Air Force staff recognized the promise of genome sequencing and engaged Coriell in a train-the-trainer capacity in anticipation of a genome-informed health model.

    Participants receive the results of their genome-wide single nucleotide polymorphisms presented in the context of their medical and personal history. “We focus on SNP genotyping,” adds Dr. Jarvis, “because whole-genome data is too difficult to interpret and present to the user in an actionable format.”

    Coriell completes genotyping with Affymetrix technology (the Genome-Wide Human SNP Array 6.0 and DMET Plus chips), and it generates reports for presentation to users.

    These reports, which detail well-replicated clinical associations, combine genetic and nongenetic risk assessments in an easy-to-read, web-based format. This presentation represents CPMC’s attempt to combine information over which the participants have full control (lifestyle choices) with inherent data (genetics and family history). Enrollees have a choice of whether or not to view reports for a particular disease association.

    “One of the study outcomes is to evaluate how the users act on this information,” says Dr. Jarvis. “Opting out from viewing it is also an outcome.” The majority of participants, however, choose to view the results, and some act on information by seeking additional disease-specific testing.

    Sharing results with treating physicians is one of the desirable outcomes sought by the CPMC, and the CPMC project uses the opportunity to outline teaching techniques and encourage doctors to incorporate genetic information at the point of care.

    A recent Coriell spin-off venture, Coriell Life Sciences, will employ lessons learned from the CPMC project and optimize the doctor-patient exchange by integrating the storage, interpretation, and delivery of genomic information.

  • Improving Variant Calling

    Rapid advances in DNA sequencing technologies have the potential to inform current and future medical care. To facilitate the broad clinical implementation of next-generation sequencing, it is critically important for genomic medicine to acquire the typical characteristics of clinical diagnostics, including clinical-grade sample collection, high-quality sequencing, and rigorous generation of variant calling.

    While the sequencing process itself is by now fairly standardized, the bioinformatic analysis and interpretive schemes are quite variable.

    Gholson Lyon, M.D., Ph.D., assistant professor of human genetics at Cold Spring Harbor Laboratory (CSHL), highlighted these differences in the interpretation of sequencing data by comparing five different alignment and variant calling software packages.

    Calling of common variants (found in over 1% of population) was relatively consistent. However, software packages called rare mutations with different accuracy. Insertions and deletions (collectively termed “indels”) presented considerable difficulty to all software packages. The position of indels is often ambiguous, and their calling could affect the outcome of clinical diagnosis.

    “Indels are an integral part of structural variant analysis,” says Dr. Lyon. “But development of indel-calling tools has been lagging.” To address this issue, Dr. Lyon is working with Michael Schatz, Ph.D., assistant professor of quantitative biology at CSHL, who is developing and validating novel indel mapping strategies.

    Dr. Lyon also suggests that de novo identification of family-inherited mutations could be significantly improved by including multiple family members in the sequencing efforts. Sequencing multigenerational pedigrees enables increased accuracy simply because the same region is now read multiple times.

    “Millions of genomes should be collated to truly understand what mutations really mean,” says Dr. Lyon. “Collaborative wiki-type annotation of variants will accelerate our understanding of phenotype-genotype relationships. The future of clinical genomics is based on the collective input of the world-wide community of scientists.”



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Mindclones and Immortality

Is the idea of making a software copy of a human mind something in the realm of reality or science fiction?